G1 Therapeutics Inc. (NASDAQ: GTHX) stock fell -3.25% on Monday to $1.49 against a previous-day closing price of $1.54. With 0.57 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.87 million shares. The 52-week range on GTHX shows that it touched its highest point at $16.10 and its lowest point at $1.53 during that stretch. It currently has a 1-year price target of $8.80. Beta for the stock currently stands at 1.87.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GTHX was down-trending over the past week, with a drop of -11.83%, but this was down by -16.76% over a month. Three-month performance dropped to -46.98% while six-month performance fell -50.50%. The stock lost -90.36% in the past year, while it has lost -72.56% so far this year. A look at the trailing 12-month EPS for GTHX yields -1.71 with Next year EPS estimates of -0.91. For the next quarter, that number is -0.33. This implies an EPS growth rate of 4.40% for this year and 5.20% for next year.
Float and Shares Shorts:
At present, 51.67 million GTHX shares are outstanding with a float of 46.29 million shares on hand for trading. On Aug 30, 2023, short shares totaled 2.93 million, which was 5.66% higher than short shares on Jul 30, 2023. In addition to Mr. John E. Bailey Jr. as the firm’s CEO, Pres & Director, Dr. Mark A. Velleca M.D., Ph.D. serves as its Sr. Advisor & Director.
Through their ownership of 44.36% of GTHX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 9.61% of GTHX, in contrast to 27.54% held by mutual funds. Shares owned by individuals account for 20.84%. As the largest shareholder in GTHX with 4.91% of the stake, Fisher Asset Management LLC holds 2,543,006 shares worth 2,543,006. A second-largest stockholder of GTHX, The Vanguard Group, Inc., holds 1,938,180 shares, controlling over 3.75% of the firm’s shares. JPMorgan Investment Management, I is the third largest shareholder in GTHX, holding 1,820,015 shares or 3.52% stake. With a 2.50% stake in GTHX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 1,295,502 shares are owned by the mutual fund manager. The Vanguard Extended Market Index Fu, which owns about 1.13% of GTHX stock, is the second-largest Mutual Fund holder. It holds 583,255 shares valued at 0.97 million. Rhenman & Partners Fund – Healthc holds 0.63% of the stake in GTHX, owning 325,000 shares worth 0.54 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, GTHX reported revenue of $10.57M and operating income of -$36.96M. The EBITDA in the recently reported quarter was -$36.90M and diluted EPS was -$0.92.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GTHX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GTHX analysts setting a high price target of $19.00 and a low target of $5.00, the average target price over the next 12 months is $10.50. Based on these targets, GTHX could surge 1175.17% to reach the target high and rise by 235.57% to reach the target low. Reaching the average price target will result in a growth of 604.7% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded GTHX stock several times over the past three months with 2 Buys and 6 Sells. In these transactions, 60,000 shares were bought while 65,796 shares were sold. The number of buy transactions has increased to 26 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 797,400 while 148,714 shares were sold.